-
VVOS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Vivos Therapeutics (VVOS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.31 mm | 6.31 mm | 6.31 mm | 6.31 mm | 6.31 mm | 6.31 mm |
Cash burn (monthly) | 197.33 k | (no burn) | 881.67 k | 1.05 mm | 1.40 mm | 1.04 mm |
Cash used (since last report) | 555.76 k | n/a | 2.48 mm | 2.96 mm | 3.93 mm | 2.93 mm |
Cash remaining | 5.76 mm | n/a | 3.83 mm | 3.35 mm | 2.38 mm | 3.38 mm |
Runway (months of cash) | 29.2 | n/a | 4.3 | 3.2 | 1.7 | 3.2 |
13F holders | Current |
---|---|
Total holders | 12 |
Opened positions | 3 |
Closed positions | 7 |
Increased positions | 2 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 9.33 mm |
Total shares | 4.98 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Gurdev Dave Singh | 3.22 mm | $0.00 |
Ronald Kirk Huntsman | 1.74 mm | $0.00 |
Commonwealth Equity Services | 16.00 k | $36.00 k |
Triad Wealth Partners | 2.82 k | $6.26 mm |
Signaturefd | 547.00 | $1.21 mm |
Group One Trading | 228.00 | $506.00 k |
Thrivent Trust Co of Tennessee | 160.00 | $773.00 k |
BAC Bank of America | 103.00 | $229.00 k |
MS Morgan Stanley | 68.00 | $151.00 k |
Kozak & Associates | 49.00 | $118.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Nov 24 | Bradford K. Amman | Stock Option Common Stock | Grant | Acquire A | No | No | 2.64 | 149,533 | 394.77 k | 180,533 |
26 Nov 24 | Ronald Kirk Huntsman | Stock Option Common Stock | Grant | Acquire A | No | No | 2.64 | 315,421 | 832.71 k | 364,755 |
20 Jun 24 | Leonard J Sokolow | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 4,000 | 9.52 k | 7,467 |
20 Jun 24 | Matthew Thompson | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 4,000 | 9.52 k | 7,067 |
20 Jun 24 | Ronald Kirk Huntsman | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 20,000 | 47.60 k | 49,334 |